Adoptive transfer of tumor-specific Th9 cells eradicates heterogeneous antigen-expressing tumor cells

被引：5

作者：

Sek, Kevin ^{[1
,2
]}

Chan, Cheok Weng ^{[1
,2
]}

Beavis, Paul A. ^{[1
,2
]}

Darcy, Phillip K. ^{[1
,2
,3
,4
]}

机构：

[1] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3000, Australia

[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia

[3] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia

[4] Monash Univ, Dept Immunol, Clayton, Vic, Australia

来源：

CANCER CELL | 2021年 / 39卷 / 12期

基金：

英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;

关键词：

CAR-T CELLS;

D O I：

10.1016/j.ccell.2021.10.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In this issue of Cancer Cell, Xue et al. demonstrate that adoptive transfer of tumor-specific Th9 cells can eradicate established tumors containing antigen-loss-variant cells (ALVs) through both direct killing and bystander effects mediated by intratumoral accumulation of extracellular ATP (eATP) that promotes monocyte infiltration and stimulation of IFN alpha/beta production.

引用

页码：1564 / 1566

页数：3

共 50 条

[31] SPECIFIC DETECTION OF CARCINOEMBRYONIC ANTIGEN-EXPRESSING TUMOR-CELLS IN BONE-MARROW ASPIRATES BY POLYMERASE CHAIN-REACTION
GERHARD, M
JUHL, H
KALTHOFF, H
SCHREIBER, HW
WAGENER, C
NEUMAIER, M
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) : 725 - 729
[32] Dendritic cells, loaded with recombinant bacteria expressing tumor antigens, induce a protective tumor-specific response
Rescigno, M
Valzasina, B
Bonasio, R
Urbano, M
Ricciardi-Castagnoli, P
CLINICAL CANCER RESEARCH, 2001, 7 (03) : 865S - 870S
[33] PREVENTION OF TUMOR GROWTH IN AN IMMUNOLOGICALLY PRIVILEGED SITE BY ADOPTIVE TRANSFER OF TUMOR-SPECIFIC TRANSPLANTATION IMMUNITY
FUTRELL, JW
ALBRIGHT, NL
MYERS, GH
JOURNAL OF SURGICAL RESEARCH, 1972, 12 (02) : 62 - &
[34] ADOPTIVE IMMUNOTHERAPY OF ESTABLISHED TUMORS - ACQUISITION OF RADIORESISTANCE BY TUMOR-SPECIFIC T-CELLS AFTER PASSIVE TRANSFER INTO TUMOR-BEARING RECIPIENTS
DUNN, PL
NORTH, RJ
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (04) : 592 - 597
[35] Prevention of carcinoma development by tumor-specific Th1 cells
Braumueller, Heidi
Wieder, Thomas
Bulotas, Gintautas
Fischer, Sonja
Roecken, Martin
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S38 - S38
[36] TRAF6 signaling pathway in T cells regulates anti-tumor immunity through the activation of tumor specific Th9 cells and CTLs
Dewayani, Astri
Kamiyama, Naganori
Sachi, Nozomi
Ozaka, Sotaro
Saechue, Benjawan
Ariki, Shimpei
Goto, Mizuki
Chalalai, Thanyakorn
Soga, Yasuhiro
Fukuda, Chiaki
Kagoshima, Yomei
Maekawa, Yoichi
Kobayashi, Takashi
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 613 : 26 - 33
[37] Tumor rejection in Cblb-/- mice depends on IL-9 and Th9 cells
Schanz, Oliver
Cornez, Isabelle
Yajnanarayana, Sowmya Parampalli
David, Friederike Sophie
Peer, Sebastian
Gruber, Thomas
Krawitz, Peter
Brossart, Peter
Heine, Annkristin
Landsberg, Jenny
Baier, Gottfried
Wolf, Dominik
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
[38] Natural killer T cells may have an important role in adoptive immunotherapy with tumor-specific T cells
不详
IMMUNOTHERAPY, 2009, 1 (05) : 735 - 736
[39] Tumor-specific CD8+Tc9 cells are superior effector than Tc1 cells for adoptive immunotherapy of cancers
Lu, Yong
Hong, Bangxing
Li, Haiyan
Zheng, Yuhuan
Zhang, Mingjun
Qian, Jianfei
Yi, Qing
JOURNAL OF IMMUNOLOGY, 2014, 192
[40] Retraction Note: Tumor-specific Th2 responses inhibit growth of CT26 colon-cancer cells in mice via converting intratumor regulatory T cells to Th9 cells
Jiang-Qi Liu
Xing-Yong Li
Hai-Qiong Yu
Gui Yang
Zhi-Qiang Liu
Xiao-Rui Geng
Shuai Wang
Li-Hua Mo
Lu Zeng
Miao Zhao
Yun-Ting Fu
Hong-Zhi Sun
Zhi-Gang Liu
Ping-Chang Yang
Scientific Reports, 11

← 1 2 3 4 5 →